CAS RN: 2040305-05-1
Ortho-Isomer of Dapagliflozin
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260327
25mg / 50mg / 100mg
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2040305-05-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
2040305-05-1 / (2S,3R,4R,5S,6R)-2-[4-chloro-3-[(2-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
Standard CAS: 2040305-05-1
Multi CAS: No
Basic Information
copy
CAS
2040305-05-1 copy
Multi CAS
No copy
Molecular Formula
C21H25ClO6 copy
Molecular Weight
408.900000 copy
Exact Mass
408.133966 copy
SMILES
CCOC1=CC=CC=C1CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Cl copy
InChI
InChI=1S/C21H25ClO6/c1-2-27-16-6-4-3-5-12(16)9-14-10-13(7-8-15(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1 copy
InChIKey
GZUADDXLXVDFHI-ADAARDCZSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
28 copy
Aromatic heavy atom count
12 copy
Fraction Csp3
0.43 copy
Rotatable bonds
6 copy
H-bond acceptors
6 copy
H-bond donors
4 copy
Molar refractivity
104.59 copy
TPSA
99.38 copy
LogP / Solubility
WLOGP
1.84 copy
MLOGP
1.65 copy
XLogP3
2.3 copy
Consensus LogP
1.93 copy
Log S (ESOL)
-3.46 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-4.24 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-4.57 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.9 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
5 copy